12月7日,2025版国家医保药品目录发布,今年新纳入目录的药品有114种,其中肿瘤治疗药物达36种,另有多种肿瘤治疗药物新增了医保覆盖的适应证。同时,今年首次设立的商保创新药目录首批纳入19种药品,其中14款为肿瘤和罕见肿瘤的创新药品,进一步构建了“医保+商保”的双重保障体系。这也是近年来医保目录最大规模的一次创新药扩容。12月9日,在2025版国家医保目录解读会上,国家医疗保障局医药管理司司长...
Source Link12月7日,2025版国家医保药品目录发布,今年新纳入目录的药品有114种,其中肿瘤治疗药物达36种,另有多种肿瘤治疗药物新增了医保覆盖的适应证。同时,今年首次设立的商保创新药目录首批纳入19种药品,其中14款为肿瘤和罕见肿瘤的创新药品,进一步构建了“医保+商保”的双重保障体系。这也是近年来医保目录最大规模的一次创新药扩容。12月9日,在2025版国家医保目录解读会上,国家医疗保障局医药管理司司长...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.